PULMATRIX, INC. Accrued Vacation, Current
PULMATRIX, INC. (PULM) had Accrued Vacation, Current of $124.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-10.
Discontinued › Notes › Payables and Accruals › Employee-related Liabilities, Current
us-gaap:AccruedVacationCurrent · last filed 2022-08-10
- 2022-06-30: Accrued Vacation, Current $124.00K.
- 2022-03-31: Accrued Vacation, Current $106.00K.
- 2021-12-31: Accrued Vacation, Current $60.00K.
- 2021-09-30: Accrued Vacation, Current $103.00K.
| Period end | Accrued Vacation, Current |
|---|---|
| 2022-06-30 | $124.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $106.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $60.00K 10-Q · filed 2022-08-10 |
| 2021-09-30 | $103.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $117.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $105.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $56.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $93.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $122.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $87.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $42.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $58.00K 10-Q · filed 2019-11-01 |
| 2019-06-30 | $82.00K 10-Q · filed 2019-08-05 |
| 2019-03-31 | $80.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $59.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $71.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $119.00K 10-Q · filed 2018-08-03 |
| 2018-03-31 | $96.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $57.00K 10-K · filed 2019-02-19 |
| 2017-09-30 | $92.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $95.00K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $75.00K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $54.00K 10-K · filed 2018-03-13 |
| 2016-09-30 | $64.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $89.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $70.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $45.00K 10-K · filed 2017-03-10 |
| 2015-09-30 | $70.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $81.00K 10-Q · filed 2015-08-14 |
| 2014-12-31 | $31.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |